151 related articles for article (PubMed ID: 24035948)
1. Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.
Li L; Sun H; Gao J; Jiang T; Gao Y; Zhang J
Pak J Pharm Sci; 2013 Sep; 26(5):929-37. PubMed ID: 24035948
[TBL] [Abstract][Full Text] [Related]
2. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
Huang G; Wang R; Wang D; Zhang Z; Deng S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
[TBL] [Abstract][Full Text] [Related]
3. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum.
Gohel MC; Parikh RK; Nagori SA; Jena DG
AAPS PharmSciTech; 2009; 10(1):62-8. PubMed ID: 19148762
[TBL] [Abstract][Full Text] [Related]
5. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
6. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention.
Narendra C; Srinath MS; Babu G
AAPS PharmSciTech; 2006 Apr; 7(2):E34. PubMed ID: 16796352
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
8. A novel system for three-pulse drug release based on "tablets in capsule" device.
Li B; Zhu J; Zheng C; Gong W
Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers.
Dadarwal SC; Madan S; Agrawal SS
Acta Pharm; 2012 Mar; 62(1):105-14. PubMed ID: 22472453
[TBL] [Abstract][Full Text] [Related]
10. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
[TBL] [Abstract][Full Text] [Related]
11. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
Gurpreetarora ; Malik K; Rana V; Singh I
Acta Pol Pharm; 2012; 69(4):725-37. PubMed ID: 22876617
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
Abd-Elbary A; Haider M; Sayed S
Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
Quinten T; De Beer T; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
[TBL] [Abstract][Full Text] [Related]
14. Core-in-cup tablet design of metoprolol succinate and its evaluation for controlled release.
Nagaraju R; Meera DS; Kaza R; Arvind VV; Venkateswarlu V
Curr Drug Discov Technol; 2009 Dec; 6(4):299-305. PubMed ID: 20025598
[TBL] [Abstract][Full Text] [Related]
15. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sodium alginate as drug release modifier in matrix tablets.
Liew CV; Chan LW; Ching AL; Heng PW
Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
[TBL] [Abstract][Full Text] [Related]
17. Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets.
Zhao N; Zidan A; Tawakkul M; Sayeed VA; Khan M
Int J Pharm; 2010 Nov; 401(1-2):25-31. PubMed ID: 20849940
[TBL] [Abstract][Full Text] [Related]
18. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
[TBL] [Abstract][Full Text] [Related]
19. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
[TBL] [Abstract][Full Text] [Related]
20. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
Chen L; Wang F
Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
